Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Patheon, a global provider of pharmaceutical development and manufacturing services, announced that Patrick Glaser was appointed senior vice president of the company’s small molecule active pharmaceutical ingredient (API) business.
read more
Friday, February 01, 2013
Patheon Inc., a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry, today announced plans for additional investment in its Milton Park facility. Located in Oxfordshire, UK, Milton ...
read more
Patheon announced it has completed an expansion project at its Greenville, NC manufacturing site.
read more
Wednesday, February 01, 2017
Patheon has completed the acquisition of a state-of-the-art manufacturing facility in Florence, South Carolina from Roche Holdings, Inc. Patheon has begun integrating the site into the Patheon network.
read more
Tuesday, December 18, 2012
Patheon Inc., a leading provider of contract development and manufacturing services to the global pharmaceutical industry, today announced that it has completed its acquisition of Banner Pharmacaps ("Banner"), a specialty pharmaceutical business ...
read more
Wednesday, December 19, 2012
Patheon Inc., a leading provider of contract development and manufacturing services to the global pharmaceutical industry, today announced that it has completed its acquisition of Banner Pharmacaps ("Banner"), a specialty pharmaceutical business ...
read more
Monday, February 08, 2016
Patheon has hired Andrew G. Long as senior vice president and global business controller. Long will report to Stuart Grant, chief financial officer for Patheon, and will be based at the company’s headquarters in Durham, N.C.
read more
Patheon, a global provider of pharmaceutical development and manufacturing services announced that Michel Lagarde has been appointed as its President, effective immediately. In this newly created role, Lagarde will lead global corporate and cross-...
read more
Tuesday, February 02, 2016
Patheon has announced the appointment of Steve Lam as senior vice president of the company’s biologics business.
read more
Patheon Inc., a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry, announced today that it will host a conference call and webcast allowing interested persons to listen to its Annual ...
read more
BiondVax Pharmaceuticals announced a patent covering production processes of the Company's M-001 universal influenza vaccine candidate was allowed in the USA and Japan.
read more
Friday, December 11, 2020
Passage Bio and Catalent announced manufacturing operations have commenced to support AAV production for Passage Bio’s lead gene therapy product candidates for the treatment of rare monogenic CNS disorders.
read more
Passage Bio has entered into a collaboration agreement with Paragon Gene Therapy for the development of a dedicated manufacturing suite at their facility near Baltimore.
read more
Wednesday, April 10, 2013
The Society for Clinical Research Sites (SCRS) is pleased to announce that President Christine Pierre has been nominated for the Clinical Trial Business Woman of the Year Award. This prestigious award, granted by the Partnerships in Clinical Trials (...
read more
Tuesday, November 09, 2021
CellVec has been selected as the manufacturer of choice for Australian cell therapy immuno-oncology company Carina Biotech, undertaking the production of GMP-compliant lentivirus constructs for its LGR5 CAR-T.
read more